Skip to content

Investigation on the Rehabilitation Efficacy of EMG-Driven Exoneuromusculoskeleton (ENMS) on Upper Limb Motor Function and Its Impact on Gait in Patients with Subacute Stroke

Investigation on the Rehabilitation Efficacy of EMG-Driven Exoneuromusculoskeleton (ENMS) on Upper Limb Motor Function and Its Impact on Gait in Patients with Subacute Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129622
Enrollment
Unknown
Registered
2026-08-07
Start date
2026-08-31
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke (including ischemic and hemorrhagic stroke)

Interventions

Experimental group (neuromusculoskeletal group):Training with external neuromusculoskeletal assistance
Control group (conventional training group):Conventional training

Sponsors

China Rehabilitation Research Center (Beijing Baode Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The first occurrence of a stroke (ischemic or hemorrhagic), with a single unilateral brain injury; 2. The onset time is within 1-6 months; 3. The age is over 18 years old; 4. The degree of motor dysfunction in the upper limb on the hemiplegic side is moderate to severe (15 < FMA-UE score < 45); 5. The score on the Mini-Mental State Examination is 21 or above; 6. Autonomous muscle electrical signals can be detected in the driving muscles on the hemiplegic side (i.e., more than three times the standard deviation above the electromyographic baseline); 7. The muscle response quality of the upper and lower limbs on the hemiplegic side on the Modified Tardieu Scale is less than 3 points; 8. BMI <= 30 kg/m^2; 9. The ability to walk independently for a distance of 10 meters.

Exclusion criteria

Exclusion criteria: 1.Epilepsy; 2.implanted cardiac pacemaker; 3.limited passive range of motion in the shoulder, elbow, wrist, or finger joints due to orthopedic issues or pain; 4.cognitive decline rendering the individual unable to follow simple instructions; 5.open wounds or skin lesions in the area of ??the muscles being stimulated; 6.balance or coordination disorders

Design outcomes

Primary

MeasureTime frame
Upper limb Fugl-Meyer motor function score;

Secondary

MeasureTime frame
MyotonPRO Muscle Hardness;Improved Tardieu Scale;Fugl-Meyer Lower Limb Motor Function Score;Gait assessment and intervention tools;Simple Upper Limb Function Examination;Stroke patient performance assessment scale;

Countries

China

Contacts

Public ContactJianan Wang

China Rehabilitation Research Center (Beijing Baode Hospital)

wangjianan286@gmail.com+86 10 8756 9510

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026